LCS
BSX icon

Levin Capital Strategies’s Boston Scientific BSX Stock Holding History

Levin Capital Strategies’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.97M Buy
+158,940
New +$12.7M 0.76% 45

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Levin Capital Strategies's BSX Position: Q1 2026 in Review

Levin Capital Strategies opened a new position in Boston Scientific (BSX) in Q1 2026: 158,940 shares worth $9.97M. The stake represents 0.76% of the portfolio and ranks #45 among its holdings.

1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Levin Capital Strategies held 158,940 shares of Boston Scientific worth $9.97M as of Q1 2026.
  • Boston Scientific was a new Levin Capital Strategies position in Q1 2026.
  • Boston Scientific made up 0.76% of Levin Capital Strategies's portfolio in Q1 2026, its #45 holding.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Levin Capital Strategies's 13F filing for Q1 2026, filed 13 May 2026.